"        According to the AP (10/22, Tanner), other "drugs under examination are Genentech Inc.'s psoriasis drug Raptiva (efalizumab), which just last week the Food and Drug Administration (FDA) warned may contribute to a life-threatening brain illness and infections; and Exubera, an inhaled insulin product, linked with lung cancer risks," which "Pfizer Inc. stopped… [read post]